Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 289 to 298 of 298 entries
Sorted by: Best Match Show Resources per page
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.

Leukemia

Salwender H, Elmaagacli A, Merz M, Miah K, Benner A, Haenel M, Jehn C, Mai EK, Bertsch U, Blau IW, Scheid C, Hose D, Seckinger A, Jauch A, Raab MS, Luntz SP, Besemer B, Munder M, Brossart P, Fuhrmann S, Lindemann HW, Weisel K, Duerig J, Goldschmidt H.
PMID: 34031532
Leukemia. 2021 Oct;35(10):3007-3011. doi: 10.1038/s41375-021-01298-y. Epub 2021 May 24.

No abstract available.

Cite
Salwender H, Elmaagacli A, Merz M, et al. Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia. 2021;35(10):3007-3011doi: 10.1038/s41375-021-01298-y.
Salwender, H., Elmaagacli, A., Merz, M., Miah, K., Benner, A., Haenel, M., Jehn, C., Mai, E. K., Bertsch, U., Blau, I. W., Scheid, C., Hose, D., Seckinger, A., Jauch, A., Raab, M. S., Luntz, S. P., Besemer, B., Munder, M., Brossart, P., Fuhrmann, S., Lindemann, H. W., Weisel, K., Duerig, J., & Goldschmidt, H. (2021). Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia, 35(10), 3007-3011. https://doi.org/10.1038/s41375-021-01298-y
Salwender, Hans, et al. "Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial." Leukemia vol. 35,10 (2021): 3007-3011. doi: https://doi.org/10.1038/s41375-021-01298-y
Salwender H, Elmaagacli A, Merz M, Miah K, Benner A, Haenel M, Jehn C, Mai EK, Bertsch U, Blau IW, Scheid C, Hose D, Seckinger A, Jauch A, Raab MS, Luntz SP, Besemer B, Munder M, Brossart P, Fuhrmann S, Lindemann HW, Weisel K, Duerig J, Goldschmidt H. Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia. 2021 Oct;35(10):3007-3011. doi: 10.1038/s41375-021-01298-y. Epub 2021 May 24. PMID: 34031532.
Copy Download .nbib Format: NLM
Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Pre-conceptional Nutritional Intervention in Mumbai, India.

The Journal of nutrition

Sahariah SA, Gandhi M, Chopra H, Kehoe SH, Johnson MJ, di Gravio C, Patkar D, Sane H, Coakley PJ, Karkera AH, Bhat DS, Brown N, Margetts BM, Jackson AA, K K, Potdar RD, Fall CHD.
PMID: 35015882
J Nutr. 2022 Jan 07; doi: 10.1093/jn/nxab443. Epub 2022 Jan 07.

BACKGROUND: Maternal nutrition influences fetal development and may permanently alter ('program') offspring body composition and metabolism, thereby influencing later risk of diabetes and cardiovascular (cardiometabolic) disease. The prevalence of cardiometabolic disease is rising rapidly in India.OBJECTIVES: To test the...

Cite
Sahariah SA, Gandhi M, Chopra H, et al. Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Pre-conceptional Nutritional Intervention in Mumbai, India. J Nutr. 2022;doi: 10.1093/jn/nxab443.
Sahariah, S. A., Gandhi, M., Chopra, H., Kehoe, S. H., Johnson, M. J., di Gravio, C., Patkar, D., Sane, H., Coakley, P. J., Karkera, A. H., Bhat, D. S., Brown, N., Margetts, B. M., Jackson, A. A., K, K., Potdar, R. D., & Fall, C. H. D. (2022). Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Pre-conceptional Nutritional Intervention in Mumbai, India. The Journal of nutrition, . https://doi.org/10.1093/jn/nxab443
Sahariah, Sirazul Ameen, et al. "Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Pre-conceptional Nutritional Intervention in Mumbai, India." The Journal of nutrition vol. (2022). doi: https://doi.org/10.1093/jn/nxab443
Sahariah SA, Gandhi M, Chopra H, Kehoe SH, Johnson MJ, di Gravio C, Patkar D, Sane H, Coakley PJ, Karkera AH, Bhat DS, Brown N, Margetts BM, Jackson AA, K K, Potdar RD, Fall CHD. Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Pre-conceptional Nutritional Intervention in Mumbai, India. J Nutr. 2022 Jan 07; doi: 10.1093/jn/nxab443. Epub 2022 Jan 07. PMID: 35015882.
Copy Download .nbib Format: NLM
Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR.

Clinical cancer research : an official journal of the American Association for Cancer Research

Bardia A, Hurvitz SA, DeMichele A, Clark AS, Zelnak A, Yardley DA, Karuturi M, Sanft T, Blau S, Hart L, Ma C, Rugo HS, Purkayastha D, Moulder S.
PMID: 33722897
Clin Cancer Res. 2021 Aug 01;27(15):4177-4185. doi: 10.1158/1078-0432.CCR-20-2114. Epub 2021 Mar 15.

PURPOSE: Standard-of-care treatment for metastatic hormone receptor-positive (HRPATIENTS AND METHODS: This multicenter, open-label, single-arm, phase I/II study included patients with locally advanced/metastatic HRRESULTS: Of 104 patients enrolled (phases I and II), 96 had prior CDK4/6i. Recommended phase II doses...

Cite
Bardia A, Hurvitz SA, DeMichele A, et al. Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR. Clin Cancer Res. 2021;27(15):4177-4185doi: 10.1158/1078-0432.CCR-20-2114.
Bardia, A., Hurvitz, S. A., DeMichele, A., Clark, A. S., Zelnak, A., Yardley, D. A., Karuturi, M., Sanft, T., Blau, S., Hart, L., Ma, C., Rugo, H. S., Purkayastha, D., & Moulder, S. (2021). Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(15), 4177-4185. https://doi.org/10.1158/1078-0432.CCR-20-2114
Bardia, Aditya, et al. "Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,15 (2021): 4177-4185. doi: https://doi.org/10.1158/1078-0432.CCR-20-2114
Bardia A, Hurvitz SA, DeMichele A, Clark AS, Zelnak A, Yardley DA, Karuturi M, Sanft T, Blau S, Hart L, Ma C, Rugo HS, Purkayastha D, Moulder S. Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR. Clin Cancer Res. 2021 Aug 01;27(15):4177-4185. doi: 10.1158/1078-0432.CCR-20-2114. Epub 2021 Mar 15. PMID: 33722897; PMCID: PMC8487593.
Copy Download .nbib Format: NLM
Multimodal nonlinear-optical imaging of nucleoli.

Optics letters

Pochechuev MS, Lanin AA, Kelmanson IV, Chebotarev AS, Fetisova ES, Bilan DS, Shevchenko EK, Ivanov AA, Fedotov AB, Belousov VV, Zheltikov AM.
PMID: 34329236
Opt Lett. 2021 Aug 01;46(15):3608-3611. doi: 10.1364/OL.416300.

Multimodal nonlinear microscopy combining third-harmonic generation (THG) with two- and three-photon-excited fluorescence (2PEF and 3PEF) is shown to provide a powerful resource for high-fidelity imaging of nucleoli and nucleolar proteins. We demonstrate that, with a suitably tailored genetically encoded...

Cite
Pochechuev MS, Lanin AA, Kelmanson IV, et al. Multimodal nonlinear-optical imaging of nucleoli. Opt Lett. 2021;46(15):3608-3611doi: 10.1364/OL.416300.
Pochechuev, M. S., Lanin, A. A., Kelmanson, I. V., Chebotarev, A. S., Fetisova, E. S., Bilan, D. S., Shevchenko, E. K., Ivanov, A. A., Fedotov, A. B., Belousov, V. V., & Zheltikov, A. M. (2021). Multimodal nonlinear-optical imaging of nucleoli. Optics letters, 46(15), 3608-3611. https://doi.org/10.1364/OL.416300
Pochechuev, M S, et al. "Multimodal nonlinear-optical imaging of nucleoli." Optics letters vol. 46,15 (2021): 3608-3611. doi: https://doi.org/10.1364/OL.416300
Pochechuev MS, Lanin AA, Kelmanson IV, Chebotarev AS, Fetisova ES, Bilan DS, Shevchenko EK, Ivanov AA, Fedotov AB, Belousov VV, Zheltikov AM. Multimodal nonlinear-optical imaging of nucleoli. Opt Lett. 2021 Aug 01;46(15):3608-3611. doi: 10.1364/OL.416300. PMID: 34329236.
Copy Download .nbib Format: NLM
The issues and complexities of establishing methodologies to differentiate between vertical and horizontal impact mechanisms in the analysis of skeletal trauma: An introductory femoral test.

Forensic science international

Dempsey N, Bassed R, Blau S.
PMID: 33866189
Forensic Sci Int. 2021 Apr 10;323:110785. doi: 10.1016/j.forsciint.2021.110785. Epub 2021 Apr 10.

Understanding skeletal trauma characteristics is fundamental for the examination and interpretation of blunt force trauma (BFT). BFT is the most complex type of trauma to interpret based on the analysis of skeletal fractures alone, with comminuted fractures presenting additional...

Cite
Dempsey N, Bassed R, Blau S. The issues and complexities of establishing methodologies to differentiate between vertical and horizontal impact mechanisms in the analysis of skeletal trauma: An introductory femoral test. Forensic Sci Int. 2021;323:110785doi: 10.1016/j.forsciint.2021.110785.
Dempsey, N., Bassed, R., & Blau, S. (2021). The issues and complexities of establishing methodologies to differentiate between vertical and horizontal impact mechanisms in the analysis of skeletal trauma: An introductory femoral test. Forensic science international, 323110785. https://doi.org/10.1016/j.forsciint.2021.110785
Dempsey, Nicholas, et al. "The issues and complexities of establishing methodologies to differentiate between vertical and horizontal impact mechanisms in the analysis of skeletal trauma: An introductory femoral test." Forensic science international vol. 323 (2021): 110785. doi: https://doi.org/10.1016/j.forsciint.2021.110785
Dempsey N, Bassed R, Blau S. The issues and complexities of establishing methodologies to differentiate between vertical and horizontal impact mechanisms in the analysis of skeletal trauma: An introductory femoral test. Forensic Sci Int. 2021 Apr 10;323:110785. doi: 10.1016/j.forsciint.2021.110785. Epub 2021 Apr 10. PMID: 33866189.
Copy Download .nbib Format: NLM
In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model.

Redox biology

Kelmanson IV, Shokhina AG, Kotova DA, Pochechuev MS, Ivanova AD, Kostyuk AI, Panova AS, Borodinova AA, Solotenkov MA, Stepanov EA, Raevskii RI, Moshchenko AA, Pak VV, Ermakova YG, van Belle GJC, Tarabykin V, Balaban PM, Fedotov IV, Fedotov AB, Conrad M, Bogeski I, Katschinski DM, Doeppner TR, Bähr M, Zheltikov AM, Belousov VV, Bilan DS.
PMID: 34773835
Redox Biol. 2021 Nov 03;48:102178. doi: 10.1016/j.redox.2021.102178. Epub 2021 Nov 03.

Ischemic cerebral stroke is one of the leading causes of death and disability in humans. However, molecular processes underlying the development of this pathology remain poorly understood. There are major gaps in our understanding of metabolic changes that occur...

Cite
Kelmanson IV, Shokhina AG, Kotova DA, et al. In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox Biol. 2021;48:102178doi: 10.1016/j.redox.2021.102178.
Kelmanson, I. V., Shokhina, A. G., Kotova, D. A., Pochechuev, M. S., Ivanova, A. D., Kostyuk, A. I., Panova, A. S., Borodinova, A. A., Solotenkov, M. A., Stepanov, E. A., Raevskii, R. I., Moshchenko, A. A., Pak, V. V., Ermakova, Y. G., van Belle, G. J. C., Tarabykin, V., Balaban, P. M., Fedotov, I. V., Fedotov, A. B., Conrad, M., Bogeski, I., Katschinski, D. M., Doeppner, T. R., Bähr, M., Zheltikov, A. M., Belousov, V. V., & Bilan, D. S. (2021). In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox biology, 48102178. https://doi.org/10.1016/j.redox.2021.102178
Kelmanson, Ilya V, et al. "In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model." Redox biology vol. 48 (2021): 102178. doi: https://doi.org/10.1016/j.redox.2021.102178
Kelmanson IV, Shokhina AG, Kotova DA, Pochechuev MS, Ivanova AD, Kostyuk AI, Panova AS, Borodinova AA, Solotenkov MA, Stepanov EA, Raevskii RI, Moshchenko AA, Pak VV, Ermakova YG, van Belle GJC, Tarabykin V, Balaban PM, Fedotov IV, Fedotov AB, Conrad M, Bogeski I, Katschinski DM, Doeppner TR, Bähr M, Zheltikov AM, Belousov VV, Bilan DS. In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox Biol. 2021 Nov 03;48:102178. doi: 10.1016/j.redox.2021.102178. Epub 2021 Nov 03. PMID: 34773835; PMCID: PMC8600061.
Copy Download .nbib Format: NLM
Mixed industrial wastewater treatment by the combination of heterogeneous electro-Fenton and electrocoagulation processes.

Chemosphere

Nidheesh PV, Behera B, Babu DS, Scaria J, Kumar MS.
PMID: 34922960
Chemosphere. 2021 Dec 16;133348. doi: 10.1016/j.chemosphere.2021.133348. Epub 2021 Dec 16.

Mixed industrial wastewater treatment efficiency of combined electro-Fenton (EF) and electrocoagulation (EC) processes was investigated in the present study. Alkali modified laterite soil was used as a heterogeneous EF catalyst and found superior performance than the raw laterite soil....

Cite
Nidheesh PV, Behera B, Babu DS, et al. Mixed industrial wastewater treatment by the combination of heterogeneous electro-Fenton and electrocoagulation processes. Chemosphere. 2021;133348doi: 10.1016/j.chemosphere.2021.133348.
Nidheesh, P. V., Behera, B., Babu, D. S., Scaria, J., & Kumar, M. S. (2021). Mixed industrial wastewater treatment by the combination of heterogeneous electro-Fenton and electrocoagulation processes. Chemosphere, 133348. https://doi.org/10.1016/j.chemosphere.2021.133348
Nidheesh, P V, et al. "Mixed industrial wastewater treatment by the combination of heterogeneous electro-Fenton and electrocoagulation processes." Chemosphere vol. (2021): 133348. doi: https://doi.org/10.1016/j.chemosphere.2021.133348
Nidheesh PV, Behera B, Babu DS, Scaria J, Kumar MS. Mixed industrial wastewater treatment by the combination of heterogeneous electro-Fenton and electrocoagulation processes. Chemosphere. 2021 Dec 16;133348. doi: 10.1016/j.chemosphere.2021.133348. Epub 2021 Dec 16. PMID: 34922960.
Copy Download .nbib Format: NLM
Chemical incidents.

BJA education

Sen JPB, Sandhu R, Bland S.
PMID: 33777410
BJA Educ. 2021 Apr;21(4):126-132. doi: 10.1016/j.bjae.2020.11.005. Epub 2021 Jan 21.

No abstract available.

Cite
Sen JPB, Sandhu R, Bland S. Chemical incidents. BJA Educ. 2021;21(4):126-132doi: 10.1016/j.bjae.2020.11.005.
Sen, J. P. B., Sandhu, R., & Bland, S. (2021). Chemical incidents. BJA education, 21(4), 126-132. https://doi.org/10.1016/j.bjae.2020.11.005
Sen, J P B, et al. "Chemical incidents." BJA education vol. 21,4 (2021): 126-132. doi: https://doi.org/10.1016/j.bjae.2020.11.005
Sen JPB, Sandhu R, Bland S. Chemical incidents. BJA Educ. 2021 Apr;21(4):126-132. doi: 10.1016/j.bjae.2020.11.005. Epub 2021 Jan 21. PMID: 33777410; PMCID: PMC7984965.
Copy Download .nbib Format: NLM
In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model.

Redox biology

Kelmanson IV, Shokhina AG, Kotova DA, Pochechuev MS, Ivanova AD, Kostyuk AI, Panova AS, Borodinova AA, Solotenkov MA, Stepanov EA, Raevskii RI, Moshchenko AA, Pak VV, Ermakova YG, van Belle GJC, Tarabykin V, Balaban PM, Fedotov IV, Fedotov AB, Conrad M, Bogeski I, Katschinski DM, Doeppner TR, Bähr M, Zheltikov AM, Belousov VV, Bilan DS.
PMID: 34773835
Redox Biol. 2021 Nov 03;48:102178. doi: 10.1016/j.redox.2021.102178. Epub 2021 Nov 03.

Ischemic cerebral stroke is one of the leading causes of death and disability in humans. However, molecular processes underlying the development of this pathology remain poorly understood. There are major gaps in our understanding of metabolic changes that occur...

Cite
Kelmanson IV, Shokhina AG, Kotova DA, et al. In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox Biol. 2021;48:102178doi: 10.1016/j.redox.2021.102178.
Kelmanson, I. V., Shokhina, A. G., Kotova, D. A., Pochechuev, M. S., Ivanova, A. D., Kostyuk, A. I., Panova, A. S., Borodinova, A. A., Solotenkov, M. A., Stepanov, E. A., Raevskii, R. I., Moshchenko, A. A., Pak, V. V., Ermakova, Y. G., van Belle, G. J. C., Tarabykin, V., Balaban, P. M., Fedotov, I. V., Fedotov, A. B., Conrad, M., Bogeski, I., Katschinski, D. M., Doeppner, T. R., Bähr, M., Zheltikov, A. M., Belousov, V. V., & Bilan, D. S. (2021). In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox biology, 48102178. https://doi.org/10.1016/j.redox.2021.102178
Kelmanson, Ilya V, et al. "In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model." Redox biology vol. 48 (2021): 102178. doi: https://doi.org/10.1016/j.redox.2021.102178
Kelmanson IV, Shokhina AG, Kotova DA, Pochechuev MS, Ivanova AD, Kostyuk AI, Panova AS, Borodinova AA, Solotenkov MA, Stepanov EA, Raevskii RI, Moshchenko AA, Pak VV, Ermakova YG, van Belle GJC, Tarabykin V, Balaban PM, Fedotov IV, Fedotov AB, Conrad M, Bogeski I, Katschinski DM, Doeppner TR, Bähr M, Zheltikov AM, Belousov VV, Bilan DS. In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model. Redox Biol. 2021 Nov 03;48:102178. doi: 10.1016/j.redox.2021.102178. Epub 2021 Nov 03. PMID: 34773835; PMCID: PMC8600061.
Copy Download .nbib Format: NLM
Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting.

JCO oncology practice

Gajra A, Zettler ME, Miller KA, Frownfelter JG, Showalter J, Valley AW, Sharma S, Sridharan S, Kish JK, Blau S.
PMID: 34506215
JCO Oncol Pract. 2022 Jan;18(1):e80-e88. doi: 10.1200/OP.21.00179. Epub 2021 Sep 10.

PURPOSE: For patients with advanced cancer, timely referral to palliative care (PC) services can ensure that end-of-life care aligns with their preferences and goals. Overestimation of life expectancy may result in underutilization of PC services, counterproductive treatment measures, and...

Cite
Gajra A, Zettler ME, Miller KA, et al. Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting. JCO Oncol Pract. 2021;18(1):e80-e88doi: 10.1200/OP.21.00179.
Gajra, A., Zettler, M. E., Miller, K. A., Frownfelter, J. G., Showalter, J., Valley, A. W., Sharma, S., Sridharan, S., Kish, J. K., & Blau, S. (2022). Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting. JCO oncology practice, 18(1), e80-e88. https://doi.org/10.1200/OP.21.00179
Gajra, Ajeet, et al. "Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting." JCO oncology practice vol. 18,1 (2022): e80-e88. doi: https://doi.org/10.1200/OP.21.00179
Gajra A, Zettler ME, Miller KA, Frownfelter JG, Showalter J, Valley AW, Sharma S, Sridharan S, Kish JK, Blau S. Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting. JCO Oncol Pract. 2022 Jan;18(1):e80-e88. doi: 10.1200/OP.21.00179. Epub 2021 Sep 10. PMID: 34506215; PMCID: PMC8758123.
Copy Download .nbib Format: NLM
Showing 289 to 298 of 298 entries